Clinical use and applications of histone deacetylase inhibitors in multiple myeloma

Nidhi Tandon, Vijay Ramakrishnan, Shaji K Kumar Division of Hematology, Mayo Clinic, Rochester, MN, USA Abstract: The incorporation of various novel therapies has resulted in a significant survival benefit in newly diagnosed and relapsed patients with multiple myeloma (MM) over the past decade. Des...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tandon N, Ramakrishnan V, Kumar SK
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/26d3b8dbfff24a37b6b8c41b820ae08f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!